Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer -- Ignore unavailable to you. Want to Upgrade?

To: VeloSpeed who wrote (1229)	7/9/1999 6:50:00 AM
From: Russian Bear	Read Replies (1) \| Respond to of 1826

VS, It is not too early. There is always potential for clinical trial developments to occur. The PII trials for prostate, ovarian and pancreatic have all been open quite long enough for good news to present itself... The major limiting factor is the rate of patient enrollment. I am not sure what the current enrollment situation is on these trials, although I know that they all started rather slowly in this regard. I expect that there will be an MGI-114 status report given in two weeks, along with the earnings release. We should learn something then. Meanwhile, enjoy the rally. <g> RB